Literature DB >> 20622307

Distal renal tubular acidosis and its relationship with hearing loss in children: preliminary report.

Mostafa Sharifian1, Nasrin Esfandiar, Samira Mazaheri, Ariana Kariminejad, Masoumeh Mohkam, Reza Dalirani, Rana Esmaili, Mitra Ahmadi, Mehrnoush Hassas-Yeganeh.   

Abstract

INTRODUCTION: In autosomal recessive distal renal tubular acidosis (DRTA), a substantial fraction of the patients have progressive bilateral sensorineural hearing loss. This coexistence is due to the mutations of a gene expressed both in the kidney and in the cochlea. The aim of this study was to assess the correlation between hearing loss and DRTA.
MATERIALS AND METHODS: In this study, 51 children diagnosed with renal tubular acidosis were evaluated. Diagnosis of DRTA was based on clinical manifestations and detection of normal anion gap metabolic acidosis, urine pH higher than 5.5, and positive urinary anion gap. Audiometry was performed in children with DRTA and sequencing of the ATP6V1B1 gene was done for those with sensorineural hearing loss.
RESULTS: Twenty-seven patients (52.9%) had DRTA, of whom 51.9% were younger than 1 year old, 55.6% were boys, and 44.4% were girls. Eleven patients (40.7%) had bilateral sensorineural hearing loss, consisting of 5 of 15 boys (33.3%) and 6 of 12 girls (50.0%). There was no correlation between hearing loss and gender. Three patients with hearing loss had mutation in the ATP6V1B1 gene (11.1% of patients with DRTA and 27.3% of patients with DRTA and hearing loss).
CONCLUSIONS: This study indicated that a significant percentage of the children with DRTA had sensorineural hearing loss and mutation in ATP6V1B1 gene. It is recommended to investigate hearing impairment in all children with DRTA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20622307

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  4 in total

1.  ATP6V1B1 mutations in distal renal tubular acidosis and sensorineural hearing loss: clinical and genetic spectrum of five families.

Authors:  Asli Subasioglu Uzak; Nilgun Cakar; Elif Comak; Fatos Yalcinkaya; Mustafa Tekin
Journal:  Ren Fail       Date:  2013-08-07       Impact factor: 2.606

2.  Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis.

Authors:  Aurélia Bertholet-Thomas; Catherine Guittet; Maria A Manso-Silván; Sophie Joukoff; Victor Navas-Serrano; Véronique Baudouin; Mathilde Cailliez; Massimo Di Maio; Olivia Gillion-Boyer; Emilija Golubovic; Jérôme Harambat; Bertrand Knebelmann; François Nobili; Robert Novo; Ludmila Podracka; Gwenaëlle Roussey-Kesler; Luc-André Granier
Journal:  Pediatr Nephrol       Date:  2021-02-26       Impact factor: 3.714

3.  Clinical profile and outcome of renal tubular disorders in children: A single center experience.

Authors:  B Vijay Kiran; H Barman; A Iyengar
Journal:  Indian J Nephrol       Date:  2014-11

4.  Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.

Authors:  Aurélia Bertholet-Thomas; Catherine Guittet; Maria A Manso-Silván; Arnaud Castang; Véronique Baudouin; Mathilde Cailliez; Massimo Di Maio; Olivia Gillion-Boyer; Emilija Golubovic; Jérôme Harambat; Alexandre Klein; Bertrand Knebelmann; François Nobili; Robert Novo; Ludmila Podracka; Gwenaëlle Roussey-Kesler; Christos Stylianou; Luc-André Granier
Journal:  Pediatr Nephrol       Date:  2020-07-26       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.